AS01B
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AS01B, covering 2019-05-29 to 2021-01-08. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants [Phase 1, Phase 2]